Jason Y Park1, Peter Clark2, Eric Londin3, Marialuisa Sponziello4, Larry J Kricka5, Paolo Fortina6. 1. Department of Pathology and Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, TX; jaspar@childrens.com. 2. Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA; 3. Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; 4. Department of Internal Medicine and Medical Specialties, University of Rome "Sapienza," Rome, Italy; 5. Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, PA; 6. Cancer Genomics Laboratory, Sidney Kimmel Cancer Center, Department of Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Department of Molecular Medicine, University of Rome "Sapienza," Rome, Italy.
Abstract
BACKGROUND: Reporting clinically actionable incidental genetic findings in the course of clinical exome testing is recommended by the American College of Medical Genetics and Genomics (ACMG). However, the performance of clinical exome methods for reporting small subsets of genes has not been previously reported. METHODS: In this study, 57 exome data sets performed as clinical (n = 12) or research (n = 45) tests were retrospectively analyzed. Exome sequencing data was examined for adequacy in the detection of potentially pathogenic variant locations in the 56 genes described in the ACMG incidental findings recommendation. All exons of the 56 genes were examined for adequacy of sequencing coverage. In addition, nucleotide positions annotated in HGMD (Human Gene Mutation Database) were examined. RESULTS: The 56 ACMG genes have 18 336 nucleotide variants annotated in HGMD. None of the 57 exome data sets possessed a HGMD variant. The clinical exome test had inadequate coverage for >50% of HGMD variant locations in 7 genes. Six exons from 6 different genes had consistent failure across all 3 test methods; these exons had high GC content (76%-84%). CONCLUSIONS: The use of clinical exome sequencing for the interpretation and reporting of subsets of genes requires recognition of the substantial possibility of inadequate depth and breadth of sequencing coverage at clinically relevant locations. Inadequate depth of coverage may contribute to false-negative clinical exome results.
BACKGROUND: Reporting clinically actionable incidental genetic findings in the course of clinical exome testing is recommended by the American College of Medical Genetics and Genomics (ACMG). However, the performance of clinical exome methods for reporting small subsets of genes has not been previously reported. METHODS: In this study, 57 exome data sets performed as clinical (n = 12) or research (n = 45) tests were retrospectively analyzed. Exome sequencing data was examined for adequacy in the detection of potentially pathogenic variant locations in the 56 genes described in the ACMG incidental findings recommendation. All exons of the 56 genes were examined for adequacy of sequencing coverage. In addition, nucleotide positions annotated in HGMD (Human Gene Mutation Database) were examined. RESULTS: The 56 ACMG genes have 18 336 nucleotide variants annotated in HGMD. None of the 57 exome data sets possessed a HGMD variant. The clinical exome test had inadequate coverage for >50% of HGMD variant locations in 7 genes. Six exons from 6 different genes had consistent failure across all 3 test methods; these exons had high GC content (76%-84%). CONCLUSIONS: The use of clinical exome sequencing for the interpretation and reporting of subsets of genes requires recognition of the substantial possibility of inadequate depth and breadth of sequencing coverage at clinically relevant locations. Inadequate depth of coverage may contribute to false-negative clinical exome results.
Authors: Seema M Jamal; Joon-Ho Yu; Jessica X Chong; Karin M Dent; Jessie H Conta; Holly K Tabor; Michael J Bamshad Journal: Am J Med Genet A Date: 2013-05 Impact factor: 2.802
Authors: Amy L McGuire; Steven Joffe; Barbara A Koenig; Barbara B Biesecker; Laurence B McCullough; Jennifer S Blumenthal-Barby; Timothy Caulfield; Sharon F Terry; Robert C Green Journal: Science Date: 2013-05-16 Impact factor: 47.728
Authors: Samuel O Oyola; Thomas D Otto; Yong Gu; Gareth Maslen; Magnus Manske; Susana Campino; Daniel J Turner; Bronwyn Macinnis; Dominic P Kwiatkowski; Harold P Swerdlow; Michael A Quail Journal: BMC Genomics Date: 2012-01-03 Impact factor: 3.969
Authors: Jennifer S Parla; Ivan Iossifov; Ian Grabill; Mona S Spector; Melissa Kramer; W Richard McCombie Journal: Genome Biol Date: 2011-09-29 Impact factor: 13.583
Authors: Michael J Clark; Rui Chen; Hugo Y K Lam; Konrad J Karczewski; Rong Chen; Ghia Euskirchen; Atul J Butte; Michael Snyder Journal: Nat Biotechnol Date: 2011-09-25 Impact factor: 68.164
Authors: James B Caress; Janel O Johnson; Yevgeniya A Abramzon; Gregory A Hawkins; J Raphael Gibbs; Elizabeth A Sullivan; Chamanpreet S Chahal; Bryan J Traynor Journal: Muscle Nerve Date: 2017-03-23 Impact factor: 3.217
Authors: Oyediran Akinrinade; Laura Ollila; Sanna Vattulainen; Jonna Tallila; Massimiliano Gentile; Pertteli Salmenperä; Hannele Koillinen; Maija Kaartinen; Markku S Nieminen; Samuel Myllykangas; Tero-Pekka Alastalo; Juha W Koskenvuo; Tiina Heliö Journal: Eur Heart J Date: 2015-06-17 Impact factor: 29.983
Authors: Keding Cheng; Huixia Chui; Larissa Domish; Angela Sloan; Drexler Hernandez; Stuart McCorrister; Alyssia Robinson; Matthew Walker; Lorea A M Peterson; Miles Majcher; Sam Ratnam; David J M Haldane; Sadjia Bekal; John Wylie; Linda Chui; Shaun Tyler; Bianli Xu; Aleisha Reimer; Celine Nadon; J David Knox; Gehua Wang Journal: J Clin Microbiol Date: 2016-06-15 Impact factor: 5.948
Authors: Anil Patwardhan; Jason Harris; Nan Leng; Gabor Bartha; Deanna M Church; Shujun Luo; Christian Haudenschild; Mark Pratt; Justin Zook; Marc Salit; Jeanie Tirch; Massimo Morra; Stephen Chervitz; Ming Li; Michael Clark; Sarah Garcia; Gemma Chandratillake; Scott Kirk; Euan Ashley; Michael Snyder; Russ Altman; Carlos Bustamante; Atul J Butte; John West; Richard Chen Journal: Genome Med Date: 2015-07-16 Impact factor: 11.117
Authors: Chen Du; Barbara N Pusey; Christopher J Adams; C Christopher Lau; William P Bone; William A Gahl; Thomas C Markello; David R Adams Journal: BMC Med Genomics Date: 2016-08-27 Impact factor: 3.063
Authors: Dale L Bodian; Elisabeth Klein; Ramaswamy K Iyer; Wendy S W Wong; Prachi Kothiyal; Daniel Stauffer; Kathi C Huddleston; Amber D Gaither; Irina Remsburg; Alina Khromykh; Robin L Baker; George L Maxwell; Joseph G Vockley; John E Niederhuber; Benjamin D Solomon Journal: Genet Med Date: 2015-09-03 Impact factor: 8.822